ZUCCONI THEODORE DANIEL

CIK 00014136991 companyNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001413699

Recent Transactions

17 trades

Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-04-16−4,000→ 27,250 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-04-16$0.89/sh+4,000→ 5,083 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-04-16$3.58/sh−4,000→ 1,083 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2017-12-14+46,875→ 46,875 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common stock
2017-05-23$2.27/sh+1,000→ 1,083 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Warrants (right to buy)
2017-01-13$0.35/sh−85→ 38 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Warrants (right to buy)
2017-01-12$0.48/sh−2,299→ 123 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2016-12-15+31,250→ 31,250 total
Award
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (right to buy)
2011-04-08+300,000→ 300,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2011-03-24$0.23/sh+370,000→ 466,343 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (Right to Buy)
2011-03-24−370,000→ 130,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (right to buy)
2009-05-21+200,000→ 200,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (right to buy)
2009-05-21+400,000→ 400,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (right to buy)
2009-05-21+1,250,000→ 1,250,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Employee Stock Option (right to buy)
2009-05-21+150,000→ 150,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (Right to Buy)
2009-03-24+500,000→ 500,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2009-02-13+500,000→ 500,000 total

Companies

GALECTIN THERAPEUTICS INC
Director, CEO and President
$GALT

Recent Filings

Address

C/O PRO-PHARMACEUTICALS, INC 7 WELLS AVENUE, SUITE 34

NEWTON, MA, 02459

View on SEC.gov